Dr Reddy’s Lab rises on launching Supamove cream

Date: 29-12-2011

Dr Reddy’s Laboratories is currently trading at Rs 1570.00, up by 4.10 points or 0.26% from its previous closing of Rs 1565.90 on the BSE.

The scrip opened at Rs. 1551.00 and has touched a high and low of Rs 1582.00 and Rs 1551.00 respectively. So far 4591 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs 1728.90 on 06-Jan-2011 and a 52 week low of Rs 1387.00 on 22-Aug-2011.

Last one week high and low of the scrip stood at Rs 1619.00 and Rs 1551.00 respectively. The current market cap of the company is Rs 26567.55 crore.

The promoters holding in the company stood at 25.61% while Institutions and Non-Institutions held 40.74% and 15.99% respectively.

Dr Reddy’s Laboratories has unveiled Supamove cream used for treating pain and inflammation in India. The cream helps in reducing pain and inflammation in patients with joint pain, arthritis, bursitis, tendinitis and lower back pain. In addition, the product has been in-licensed from Cymbiotics Inc. USA and will be available in a 30 gm tube.

The company has also launched another product, Venusia Soft lotion in 75 ml pack, used for providing relief from dry, itchy skin also in-licensed from Cymbiotics Inc.

Dr Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs.


 

Latest Financials

Latest Financials

 - Dr. Reddys Laboratories Ltd.

  Standalone Consolidated
TTM EPS (Rs) 54.39 81.68
TTM Sales (Rs. Cr.) 9,757 14,204
BVPS (Rs.)
The total value that a company will fetch upon liquidation (if it is closed down), after settling all obligations is called its Book Value. Book value of a company includes only tangible assets. Book value allocated to each outstanding share is called Book Value per share
725.95 780.32
Reserves (Rs. Cr.)
The term reserve represents a part of shareholders' equity, except for basic share capital. Reserves are created from retained earnings and shareholders' contributions in the form of share premium etc.
11,971 12,874
P/BV
Price to Book Value is the ratio of stock's market value to its book value. It gives some idea of whether investors are paying too much for what would be left if the company went bankrupt immediately. To get high returns, it is advisable to invest in a company which satisfies all the criteria set by MoneyWorks4me and which has low price to book value ratio.
3.51 3.26
PE
It is the ratio of market price and earnings per share. It shows what the market is willing to pay for the company's earnings. To get high returns it is advisable to invest in the company which satisfies all the criteria set by MoneyWorks4me and which has low price to earnings ratio as compared to the industry.
46.82 31.18
From the Market
52 Week High / Low (Rs) 2687.45/1888.00
All Time High / Low (Rs) 4382.95/6.25
Volume Traded 1,10,375
Market Cap (Rs. Cr.) 42,286
Equity (Rs. Cr.) 83.02
Face Value (Rs) 5
Industry PE
Industry price to earnings per share tells on an average, what the market is willing to pay for overall earnings in that industry. It can be used as a benchmark price to earnings ratio for the companies in that industry.
36.55
2546.65 -15.70 (-0.61%)
Oct 19, 17:59
Return to Top
Puchho Befikar
Puchho Befikar with Emoji
Want to know if Dr. Reddys Laboratories Ltd. is right? And more..
Request Call Back
Invalid Mobile Number
Thanks.
We will call you shortly.